Coronavac, a new coronavirus vaccine developed by Beijing Sinovac. Brazilian website "G1"
[South American Overseas Chinese News Network compiled Niu Bowen report on April 7] Brazilian research team Vebra Covid-19 recently conducted a study of more than 60,000 health professionals in Manaus (Manaus) , Coronavac, a new crown vaccine developed by Beijing Sinovac, is effective against the variant new crown virus originally discovered in Manaus. The effective rate of preventing the variant virus is 50% within 14 days after the first dose.
Brazil's "São Paulo Page" reported on April 6 that the coordinator and scientist Julio Croda of the study stated that "the results are encouraging." He said: "This shows that Coronavac continues to be effective against the mutated new coronavirus originally found in Manaus, and can be used for new variants worldwide." Croda emphasized that the new coronavirus variant found in Brazil _ span6span is already prevalent in many Latin American countries, so this finding is very important.
It is reported that this study is the first time that the Vebra Covid-19 team has studied the mutant virus. The team is composed of researchers from domestic and international institutions in Brazil, as well as staff from the health bureaus of Amazonas (AM) and São Paulo (SP), and is supported by the Pan American Health Organization (PAHO).
(Editor: Li Nan)
.-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-